Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017 (2017), Article ID 8925132, 10 pages
https://doi.org/10.1155/2017/8925132
Research Article

Avoidance of Total Knee Arthroplasty in Early Osteoarthritis of the Knee with Intra-Articular Implantation of Autologous Activated Peripheral Blood Stem Cells versus Hyaluronic Acid: A Randomized Controlled Trial with Differential Effects of Growth Factor Addition

1Department of Orthopedic Surgery, Police General Hospital, Bangkok, Thailand
2THAI StemLife Co. Ltd., Bangkok, Thailand
3Department of Gynecology and Obstetrics, Police General Hospital, Bangkok, Thailand

Correspondence should be addressed to Konstantinos I. Papadopoulos; ht.oc.efilmetsiaht@satsok

Received 20 May 2017; Revised 25 July 2017; Accepted 24 August 2017; Published 19 September 2017

Academic Editor: Pei Ming

Copyright © 2017 Thana Turajane et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. M. Roos and N. K. Arden, “Strategies for the prevention of knee osteoarthritis,” Nature Reviews Rheumatology, vol. 12, no. 2, pp. 92–101, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Wan, J. Hu, Q. Zhou, J. Wang, P. Liu, and Y. Wei, “Application of co-expressed genes to articular cartilage: new hope for the treatment of osteoarthritis (review),” Molecular Medicine Reports, vol. 6, pp. 16–18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C. J. Centeno, H. Al-Sayegh, J. Bashir, S. Goodyear, and M. D. Freeman, “A dose response analysis of a specific bone marrow concentrate treatment protocol for knee osteoarthritis,” BMC Musculoskeletal Disorders, vol. 16, no. 1, p. 258, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. L. Zhou, B. Warycha, and H. Vu, “Stem cell therapy: future of pain medicine, editorial for BJMP,” British Journal of Medical Practitioners, vol. 7, no. 3, article a728, 2014. View at Google Scholar
  5. K. T. Kim, S. Lee, D. O. Ko, B. S. Seo, W. S. Jung, and B. K. Chang, “Causes of failure after total knee arthroplasty in osteoarthritis patients 55 years of age or younger,” Knee Surgery & Related Research, vol. 26, no. 1, pp. 13–19, 2014. View at Publisher · View at Google Scholar
  6. J. Julin, E. Jämsen, T. Puolakka, Y. T. Konttinen, and T. Moilanen, “Younger age increases the risk of early prosthesis failure following primary total knee replacement for osteoarthritis. A follow-up study of 32,019 total knee replacements in the Finnish Arthroplasty Register,” Acta Orthopaedica, vol. 81, no. 4, pp. 413–419, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Bert, “Abandoning microfracture of the knee: has the time come?” Arthroscopy, vol. 31, no. 3, pp. 501–505, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Lubowitz, “Editorial commentary: knee hyaluronic acid viscosupplementation reduces osteoarthritis pain,” Arthroscopy, vol. 10, p. 2046, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. V. M. Goldberg and J. A. Buckwalter, “Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity,” Osteoarthritis and Cartilage, vol. 13, pp. 216–224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. R. F. LaPrade, L. S. Bursch, E. J. Olson, V. Havlas, and C. S. Carlson, “Histologic and immunohistochemical characteristics of failed articular cartilage resurfacing procedures for osteochondritis of the knee: a case series,” The American Journal of Sports Medicine, vol. 36, pp. 360–368, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. C. C. Wyles, M. T. Houdek, A. Behfar, and R. J. Sierra, “Mesenchymal stem cell therapy for osteoarthritis: current perspectives,” Stem Cells Cloning, vol. 8, pp. 117–124, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Emadedin, N. Aghdami, L. Taghiyar et al., “Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis,” Archives of Iranian Medicine, vol. 15, pp. 422–428, 2012. View at Publisher · View at Google Scholar
  13. K. Y. Saw, A. Anz, S. Merican et al., “Articular cartilage regeneration with autologous peripheral blood progenitor cells and hyaluronic acid after arthroscopic subchondral drilling: a report of 5 cases with histology,” Arthroscopy, vol. 27, pp. 493–506, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Y. Saw, A. Anz, C. Siew-Yoke Jee et al., “Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial,” Arthroscopy, vol. 29, pp. 684–694, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Buda, F. Vannini, M. Cavallo et al., “One-step arthroscopic technique for the treatment of osteochondral lesions of the knee with bone-marrow-derived cells: three years results,” Musculoskeletal Surgery, vol. 97, pp. 145–151, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Y. Saw, A. Anz, C. S. Jee, R. C. Ng, N. Mohtarrudin, and K. Ragavanaidu, “High tibial osteotomy in combination with chondrogenesis after stem cell therapy: a histologic report of 8 cases,” Arthroscopy, vol. 31, no. 10, pp. 1909–1920, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Turajane, T. Thitiset, S. Honsawek, U. Chaveewanakorn, J. Aojanepong, and K. I. Papadopoulos, “Assessment of chondrogenic differentiation potential of autologous activated peripheral blood stem cells on human early osteoarthritic cancellous tibial bone scaffold,” Musculoskeletal Surgery, vol. 98, no. 1, pp. 35–43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Turajane, U. Chaveewanakorn, V. Larbpiboonpong et al., “Combination of intraarticular autologous activated peripheral blood stem cells with growth factor addition/preservation and hyaluronic acid in conjunction with arthroscopic microdrilling mesenchymal cell stimulation improves quality of life and regenerates articular cartilage in early osteoarthritic knee disease,” Journal of the Medical Association of Thailand, vol. 96, pp. 580–588, 2013. View at Google Scholar
  19. http://cartilage.org/society/publications/icrs-score/.
  20. C. R. Chu, A. A. Williams, C. H. Coyle, and M. E. Bowers, “Early diagnosis to enable early treatment of pre-osteoarthritis,” Arthritis Research & Therapy, vol. 14, no. 3, p. 12, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Akiyama and V. Lefebvre, “Unraveling the transcriptional regulatory machinery in chondrogenesis,” Journal of Bone and Mineral Metabolism, vol. 29, pp. 390–395, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J. A. Singh, “Stem cells and other innovative intra-articular therapies for osteoarthritis: what does the future hold?” BMC Medicine, vol. 10, p. 44, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. U. Axdorph Nygell, A. Sollén-Nilsson, and J. Lundahl, “Eighteen years’ experience of granulocyte donations-acceptable donor safety?” Journal of Clinical Apheresis, vol. 30, no. 5, pp. 265–272, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Bendall, “Extracellular molecules in hematopoietic stem cell mobilisation,” International Journal of Hematology, vol. 105, no. 2, pp. 118–128, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. S. Kim, Y. J. Choi, and Y. G. Koh, “Mesenchymal stem cell implantation in knee osteoarthritis: an assessment of the factors influencing clinical outcomes,” The American Journal of Sports Medicine, vol. 43, no. 9, pp. 2293–2301, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. X. P. Huang, Z. Sun, Y. Miyagi et al., “Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair,” Circulation, vol. 122, no. 23, pp. 2419–2429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. E. Ryan, P. Lohan, L. O'Flynn et al., “Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation,” Molecular Therapy, vol. 22, no. 3, pp. 655–667, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Seifert, M. Stolk, D. Polenz, and H. D. Volk, “Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection,” Frontiers in Immunology, vol. 3, p. 202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Kudo-Saito, “Cancer-associated mesenchymal stem cells aggravate tumor progression,” Frontiers in Cell and Development Biology, vol. 3, p. 23, 2015. View at Publisher · View at Google Scholar
  30. Q. A. Rafiq, K. Twomey, M. Kulik et al., “Developing an automated robotic factory for novel stem cell therapy production,” Regenerative Medicine, vol. 11, no. 4, pp. 351–354, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Bentivegna, M. Miloso, G. Riva et al., “DNA methylation changes during in vitro propagation of human mesenchymal stem cells: implications for their genomic stability?” Stem Cells International, vol. 2013, Article ID 192425, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Lawall, P. Bramlage, and B. Amann, “Treatment of peripheral arterial disease using stem and progenitor cell therapy,” Journal of Vascular Surgery, vol. 53, no. 2, pp. 445–453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. C. Canizo, F. Lozano, J. R. Gonzalez-Porras et al., “Peripheral endothelial progenitor cells (CD133+) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up,” Cytotherapy, vol. 9, pp. 99–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. F. A. Kudo, T. Nishibe, M. Nishibe, and K. Yasuda, “Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia,” International Angiology, vol. 22, pp. 344–348, 2003. View at Google Scholar
  35. T. Gómez-Leduc, M. Hervieu, F. Legendre et al., “Chondrogenic commitment of human umbilical cord blood-derived mesenchymal stem cells in collagen matrices for cartilage engineering,” Scientific Reports, vol. 6, article 32786, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Skowroński and M. Rutka, “Osteochondral lesions of the knee reconstructed with mesenchymal stem cells - results,” Ortopedia, Traumatologia, Rehabilitacja, vol. 15, no. 3, pp. 195–204, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. S. J. Wang, M. H. Yin, D. Jiang et al., “The chondrogenic potential of progenitor cells derived from peripheral blood: a systematic review,” Stem Cells and Development, vol. 25, no. 16, pp. 1195–1207, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Maes, E. Araldi, K. Haigh et al., “VEGF-independent cell-autonomous functions of HIF-1a regulating oxygen consumption in fetal cartilage are critical for chondrocyte survival,” Journal of Bone and Mineral Research, vol. 27, pp. 596–609, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Li, R. Yuan, T. Chen, L. Chen, and X. Jin, “Effect of platelet trich plasma and latissimus dorsi muscle flap on osteogenesis and vascularization of tissue-engineered bone in dog,” Journal of Oral and Maxillofacial Surgery, vol. 67, pp. 1850–1858, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Parsons, K. Hesselden, A. Butcher, J. Maughan, R. Milner, and A. Horner, “The biological effect of platelet rich-plasma on the fracture healing process,” Journal of Bone and Joint Surgery British Volume (London), vol. 91B, Supplement 2, p. 293-c, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. W. Wu, F. Chen, Y. Liu, Q. Ma, and T. Mao, “Autologous injectable tissue-engineered cartilage by using platelet-rich plasma: experimental study in a rabbit model,” Journal of Oral and Maxillofacial Surgery, vol. 65, pp. 1951–1957, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Mishra, P. Tummala, A. King et al., “Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation,” Tissue Engineering Part C, Methods, vol. 15, pp. 431–435, 2009. View at Google Scholar
  43. F. P. Barry, R. E. Boynton, S. Haynesworth, J. M. Murphy, and J. Zaia, “The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105),” Biochemical and Biophysical Research Communications, vol. 265, no. 1, pp. 134–139, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. M. K. Wang, H. Q. Sun, Y. C. Xiang, F. Jiang, Y. P. Su, and Z. M. Zou, “Different roles of TGF-β in the multi-lineage differentiation of stem cells,” World Journal of Stem Cells, vol. 4, no. 5, pp. 28–34, 2012. View at Publisher · View at Google Scholar
  45. J. Freitag, D. Bates, R. Boyd et al., “Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy - a review,” BMC Musculoskeletal Disorders, vol. 17, p. 230, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Sasaki, R. Kuroda, K. Ishida et al., “Enhancement of tendon-bone osteointegration of anterior cruciate ligament graft using granulocyte colony-stimulating factor,” The American Journal of Sports Medicine, vol. 36, pp. 1519–1527, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Fujihara, T. Takato, and K. Hoshi, “Macrophage-inducing FasL on chondrocytes forms immune privilege in cartilage tissue engineering, enhancing in vivo regeneration,” Stem Cells, vol. 32, no. 5, pp. 1208–1219, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. O. Grimsholm, Y. Guo, T. Ny, and S. Forsgren, “Expression patterns of neurotrophins and neurotrophin receptors in articular chondrocytes and inflammatory infiltrates in knee joint arthritis,” Cells, Tissues, Organs, vol. 188, pp. 299–309, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Welte, E. Platzer, L. Lu et al., “Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 5, pp. 1526–1530, 1985. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Tönges, J. C. Schlachetzki, J. H. Weishaupt, and M. Bähr, “Hematopoietic cytokines - on the verge of conquering neurology,” Current Molecular Medicine, vol. 7, no. 2, pp. 157–170, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Lee, M. Aoki, T. Kondo et al., “Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 12, pp. 2535–2541, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Wallner, S. Peters, C. Pitzer, H. Resch, U. Bogdahn, and A. Schneider, “The granulocyte-colony stimulating factor has a dual role in neuronal and vascular plasticity,” Frontiers in Cell and Development Biology, vol. 3, p. 48, 2015. View at Publisher · View at Google Scholar
  53. K. I. Papadopoulos, S. S. Low, T. C. Aw, and T. Chantarojanasiri, “Safety and feasibility of autologous umbilical cord blood transfusion in 2 toddlers with cerebral palsy and the role of low dose granulocyte-colony stimulating factor injections,” Restorative Neurology and Neuroscience, vol. 29, no. 1, pp. 17–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. M. F. Liao, S. R. Yeh, A. L. Lo et al., “An early granulocyte colony-stimulating factor treatment attenuates neuropathic pain through activation of mu opioid receptors on the injured nerve,” Scientific Reports, vol. 6, p. 25490, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. S. M. Xu and T. Liang, “Clinical observation of the application of autologous peripheral blood stem cell transplantation for the treatment of diabetic foot gangrene,” Experimental and Therapeutic Medicine, vol. 11, no. 1, pp. 283–288, 2016. View at Publisher · View at Google Scholar · View at Scopus
  56. K. S. Kim, Y. S. Song, J. Jin et al., “Granulocyte-colony stimulating factor as a treatment for diabetic neuropathy in rat,” Molecular and Cellular Endocrinology, vol. 414, pp. 64–72, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. M. C. Lee, J. A. McCubbin, A. D. Christensen, D. P. Poole, P. Rajasekhar, and T. Lieu, “G-CSF receptor blockade ameliorates arthritic pain and disease,” Journal of Immunology, vol. 198, no. 9, pp. 3565–3575, 2017. View at Publisher · View at Google Scholar
  58. J. A. Hamilton, A. D. Cook, and P. P. Tak, “Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases,” Nature Reviews Drug Discovery, vol. 16, no. 1, pp. 53–70, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Hara, S. Yuasa, K. Shimoji et al., “G-CSF influences mouse skeletal muscle development and regeneration by stimulating myoblast proliferation,” The Journal of Experimental Medicine, vol. 208, no. 4, pp. 715–727, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. N. Hayashiji, S. Yuasa, Y. Miyagoe-Suzuki et al., “G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy,” Nature Communications, vol. 6, p. 6745, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Casteilla, V. Planat-Benard, P. Laharrague, and B. Cousin, “Adipose-derived stromal cells: their identity and uses in clinical trials, an update,” World Journal of Stem Cells, vol. 3, no. 4, pp. 25–33, 2011. View at Publisher · View at Google Scholar
  62. N. San Martín and B. G. Gálvez, “A new paradigm for the understanding of obesity: the role of stem cells,” Archives of Physiology and Biochemistry, vol. 117, no. 3, pp. 188–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. D. L. Roberts, C. Dive, and A. G. Renehan, “Biological mechanisms linking obesity and cancer risk: new perspectives,” Annual Review of Medicine, vol. 61, pp. 301–316, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. S. M. Kwon, J. H. Lee, S. H. Lee et al., “Cross talk with hematopoietic cells regulates the endothelial progenitor cell differentiation of CD34 positive cells,” PLoS One, vol. 9, no. 8, article e106310, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Ogawa, A. C. LaRue, and M. Mehrotra, “Hematopoietic stem cells are pluripotent and not just “hematopoietic”,” Blood Cells, Molecules & Diseases, vol. 51, pp. 3–8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. O. Ham, C. Y. Lee, R. Kim et al., “Therapeutic potential of differentiated mesenchymal stem cells for treatment of osteoarthritis,” International Journal of Molecular Sciences, vol. 16, no. 7, pp. 14961–14978, 2015. View at Publisher · View at Google Scholar